Foghorn Therapeutics Newsroom

Wall Street Analysts See a 104.08% Upside in Foghorn Therapeutics (FHTX): Can the Stock Really Move This High?

Yahoo FinanceNov 25 09:55 ET

Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines and Montai Therapeutics Under Its Strategic Partnership With Pfizer

PR NewswireNov 20 06:30 ET

Foghorn Therapeutics (FHTX) Collaborates With Eli Lilly and Surpasses Q3 Expectations

TipRanksNov 13 05:47 ET

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

GlobeNewswireNov 12 07:54 ET

Express News | Foghorn Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results

BenzingaNov 5 15:51 ET

H.C. Wainwright Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 5 06:36 ET · Ratings

TD Cowen Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating

Moomoo NewsNov 4 19:33 ET · Ratings

TD Cowen Keeps Their Buy Rating on Foghorn Therapeutics (FHTX)

TipRanksNov 4 19:16 ET · Ratings

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses Revenue Estimates

Zacks Nov 4 16:45 ET

Express News | Foghorn Therapeutics Inc.: Cash, Cash Equivalents, and Marketable Securities of $267.4 Mln as of September 30, 2024, Provides Cash Runway Into 2027

ReutersNov 4 16:31 ET

Foghorn Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 4 16:22 ET · Announcements

Press Release: Foghorn Therapeutics Provides Third Quarter 2024 Financial and Corporate Update

Dow JonesNov 4 16:05 ET

Express News | Foghorn Therapeutics Q3 Net Income USD -19.122 Million

ReutersNov 4 16:05 ET

Express News | Foghorn Therapeutics Q3 Collaboration Revenue USD 7.808 Million

ReutersNov 4 16:05 ET

Express News | Foghorn Therapeutics Q3 EPS USD -0.31

ReutersNov 4 16:05 ET

Express News | Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

ReutersOct 23 08:00 ET

Press Release: Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Dow JonesOct 23 08:00 ET

More Unpleasant Surprises Could Be In Store For Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Shares After Tumbling 28%

Simply Wall StOct 22 06:43 ET

Foghorn Therapeutics Unveils Clinical Pipeline Progress

TipRanksOct 10 07:47 ET

Express News | Foghorn Therapeutics Announces First Patient Dosed With First-in-Class Oral Smarca2 Selective Inhibitor Fhd-909 in a Phase 1 Trial for Smarca4 Mutated Solid Tumors

ReutersOct 10 07:00 ET